PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announces receipt of the CE Mark for the Company’s ...

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor ...

Derma Sciences CEO Ed Quilty stated, "We are fully aware that, although the benefits of MEDIHONEY have captured the imagination of the public and the medical community alike, it is only through ...

Medihoney™antibacterial Leptospermum (Manuka) honey eradicates MRSA from 70% of chronic venous ulcers and stimulates healing in chronic wounds Superbug – methicillin-resistant Staphylococcus aureus ...

Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K. Barry J. Wolfenson, 609-514-4744Executive Vice President, Global Marketing ...

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today announced that it has purchased the MEDIHONEY® brand ...

The Te Puke-based company told shareholders in October that it expects to post a loss for its first half. Photo / Bay of Plenty Times Comvita, the manuka honey products company, has sold its Medihoney ...

Add articles to your saved list and come back to them any time. Natural healthcare products company Comvita is to buy Australian firm Medihoney in an $A6 million deal ...

Medihoney™antibacterial Leptospermum (Manuka) honey eradicates MRSA from 70% of chronic venous ulcers and stimulates healing in chronic wounds Superbug – methicillin-resistant Staphylococcus aureus ...

Add articles to your saved list and come back to them any time. Natural healthcare products company Comvita is to buy Australian firm Medihoney in an $A6 million deal ...